To identify the presence of type 2 diabetes patients with elevated insulin clearance and clarify there clinical characteristics. determine factors that affect on blood insulin concentrations at steady state in hyperinsulinemic-euglycemic clamp test (insulin clearance).

To identify the presence of type 2 diabetes patients with elevated insulin clearance and clarify there clinical characteristics. - Identification of the presence of type 2 diabetes patients with elevated insulin clearance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032014

Enrollment

100

Registered

2019-04-01

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Untreated type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: newly diagnosed and drug-treatment naive patient with type 2 diabetes mellitus

Exclusion criteria

Exclusion criteria: ketoacidosis, pregnancy, cancer, thyroid disease, adrenal tumor, renal failure, active infection, inflammatory disease, autoimmune disease, liver cirrhosis, Viral hepatitis, dementia, schizophrenia, and those who did not accept to have hyperinsulinemic-euglycemic clamp examination.

Design outcomes

Primary

Measure	Time frame
To identify patients with elevated insulin clearance assessed by hyperinsulinemic-euglycemic clamp test.	—

Secondary

Measure	Time frame
To clarify there clinical characteristics.	—

Countries

Japan

Contacts

Public ContactNoboru Kurinami

Jinnouchi Hospital Diabetes Care Center

kurinami@jinnouchi.or.jp096-363-0011

Outcome results